“We are very pleased with what the company was able to accomplish in 2022 in a challenging business environment. The results we achieved are a result of the talent and hard work of our team,” explained Dave Gulezian, Co-Founder & CEO of Alucio.
SAN FRANCISCO (PRWEB) January 12, 2023
Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, delivered another strong year of growth in FY 2022. The company reached meaningful milestones in terms of product development, customer expansion and financial metrics.
Over the past year, the Alucio product team introduced a number of impactful enhancements to the company’s flagship Beacon scientific exchange platform. These updates included expanding the types of content supported by Beacon to create rich content such as custom web applications, videos and animation files, as well as integrating an AI/ML-enabled, full-text search capability into the system.
The company also enhanced its unique presentation builder feature within Beacon, and further expanded the tool’s data and analytics capabilities. Moreover, Alucio deepened its expertise integrating Beacon with various industry content management systems (CMS) and customer relationship management (CRM) platforms to ensure compatibility with existing pharma technology infrastructure.
In 2022, the company solidified partnerships with a number of new life science customers across both Medical Affairs and Market Access teams. Additionally, Alucio’s customer set now includes Medical Device & Diagnostics companies who are leveraging Beacon to address additional business needs and use cases. Overall, the company maintains a robust and diverse group of customers that range from small, pre-commercial biotechnology companies to top-ten, global pharmaceutical manufacturers with extensive product portfolios.
As a result of these new customer additions and existing customer expansions, Beacon’s user count grew by almost 40% in 2022 as compared to the prior year. Similarly, annual recurring revenue (ARR) grew by near 50% over this same period while the company’s core financial metrics remained solid.
“We are very pleased with what the company was able to accomplish in 2022 in a challenging business environment. The results we achieved are a result of the talent and hard work of our team,” explained Dave Gulezian, Co-Founder & CEO of Alucio. “We are excited about what’s next for the company and look forward to our continued progress as an organization.”
Alucio is dedicated to the development of innovative software applications specifically for the life sciences industry. Alucio’s flagship product, Beacon, is a cloud-based scientific exchange platform that enhances scientific dialogue and engagement between life science companies and healthcare professionals. For more information, please visit the company’s website at http://www.alucio.io or contact Lisa Amin at email@example.com (925) 788-3533.